132 related articles for article (PubMed ID: 1708945)
1. Fludarabine phosphate in refractory hairy cell leukemia.
Kraut EH; Chun HG
Am J Hematol; 1991 May; 37(1):59-60. PubMed ID: 1708945
[TBL] [Abstract][Full Text] [Related]
2. Cross-resistance to purine analogs in hairy cell leukemia.
Kraut EH
Ann Intern Med; 1994 Feb; 120(3):247-8. PubMed ID: 7506014
[No Abstract] [Full Text] [Related]
3. Fludarabine phosphate therapy in other lymphoid malignancies.
Kantarjian HM; Redman JR; Keating MJ
Semin Oncol; 1990 Oct; 17(5 Suppl 8):66-70. PubMed ID: 1699285
[TBL] [Abstract][Full Text] [Related]
4. Fludarabine shows promise for some leukemia patients.
Oncology (Williston Park); 1989 Mar; 3(3):14. PubMed ID: 2484283
[No Abstract] [Full Text] [Related]
5. Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies.
Chun HG; Leyland-Jones B; Cheson BD
J Clin Oncol; 1991 Jan; 9(1):175-88. PubMed ID: 1702143
[TBL] [Abstract][Full Text] [Related]
6. Fludarabine phosphate--looking forward.
Cheson BD
Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-2. PubMed ID: 1699277
[No Abstract] [Full Text] [Related]
7. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: biology, clinical impact, and future directions.
Robertson LE; Keating MJ
Cancer Treat Res; 1993; 64():105-19. PubMed ID: 7680874
[No Abstract] [Full Text] [Related]
8. Fludarabine phosphate: an effective therapy for lymphoid malignancies.
Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-78. PubMed ID: 1699278
[No Abstract] [Full Text] [Related]
9. Fludarabine in chronic leukaemia.
Astrow AB
Lancet; 1996 May; 347(9013):1420-1. PubMed ID: 8676619
[No Abstract] [Full Text] [Related]
10. Fludarabine phosphate in lymphoma: an important new therapeutic agent.
McLaughlin P; Robertson LE; Keating MJ
Cancer Treat Res; 1996; 85():3-14. PubMed ID: 9043771
[No Abstract] [Full Text] [Related]
11. Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer. A Southwest Oncology Group Study.
Von Hoff DD; Green S; Alberts DS; Stock-Novack DL; Surwit EA; Miller TP; Stephens RL
Am J Clin Oncol; 1991 Jun; 14(3):193-4. PubMed ID: 1709556
[TBL] [Abstract][Full Text] [Related]
12. Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.
Binet JL
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):5-7. PubMed ID: 7685518
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of fludarabine phosphate (NSC 312887) in patients with advanced cervical cancer. A Southwest Oncology Group study.
Von Hoff DD; Green S; Surwit EA; Hannigan EV; Alberts DS
Am J Clin Oncol; 1990 Oct; 13(5):433-5. PubMed ID: 1699401
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fludarabine phosphate in patients with recurrent glioma.
Cascino TL; Brown LD; Morton RF; Everson LK; Marschke RF; Dinapoli RP; O'Fallon JR
Am J Clin Oncol; 1988 Oct; 11(5):586-8. PubMed ID: 2459951
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of Sézary syndrome with lymphomatous transformation to large cell lymphoma with fludarabine phosphate.
Nikko AP; RutherFord CJ; Pandya AG
Arch Dermatol; 1996 Aug; 132(8):978-9. PubMed ID: 8712858
[No Abstract] [Full Text] [Related]
16. Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
Rossi JF; van Hoof A; de Boeck K; Johnson SA; Bron D; Foussard C; Lister TA; Berthou C; Kramer MH; Littlewood TJ; Marcus RE; Deconinck E; Montillo M; Guibon O; Tollerfield SM
J Clin Oncol; 2004 Apr; 22(7):1260-7. PubMed ID: 15051774
[TBL] [Abstract][Full Text] [Related]
17. Critical review of the determination process by the Japanese reviewing authority in approving the additional efficacy of fludarabine phosphate.
Narimatsu H; Oiso G; Ono S; Kami M
J Clin Oncol; 2009 Dec; 27(34):e236-8. PubMed ID: 19884538
[No Abstract] [Full Text] [Related]
18. Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma.
Rodriguez G
Invest New Drugs; 1994; 12(2):75-92. PubMed ID: 7532163
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of fludarabine phosphate in renal cell carcinoma: a Southwest Oncology Group Study.
Balducci L; Blumenstein B; Von Hoff DD; Davis M; Hynes HE; Bukowski RM; Crawford ED
Cancer Treat Rep; 1987 May; 71(5):543-4. PubMed ID: 2436773
[No Abstract] [Full Text] [Related]
20. Phase II trial of fludarabine in patients with epithelial ovarian cancer.
Kavanagh JJ; Stringer CA; Copeland LJ; Gershenson DM; Saul P
Cancer Treat Rep; 1986 Mar; 70(3):425-6. PubMed ID: 2420446
[No Abstract] [Full Text] [Related]
[Next] [New Search]
